Latest COVID-19 Developments: New Symptoms, Steroid Treatment, Cytokine Release Syndrome, Chronic COVID-19, Endocrine Effects, Airborne Spread

Caused by the novel coronavirus (SARS-CoV-2), and affecting the whole world, the COVID-19 pandemic is becoming better understood through new research every day. Let us take a closer look at the latest published developments.
New symptoms observed in COVID-19
Dermatologists studied a small number of COVID-19 patients to determine whether rashes observed on the oral mucosa (enanthem) could be a new symptom of the virus alongside skin rashes.
For the study, the oral cavities of 21 patients diagnosed with COVID-19 between 30 March and 8 April who complained of skin rashes were examined. The enanthems observed in patients were divided into 4 categories: petechial, macular, petechial and macular, or erythematous vesicular. Patients examined during the study had one of these categories of complaints. Dr. Jimenez-Cauhe comments on the findings as follows: “We think that oral lesions observed 12 days after the onset of COVID-19 symptoms may be associated with SARS-CoV-2. Severe coughing resulting from lung damage can also cause lesions on the palate, but this is unlikely because they appeared simultaneously with COVID-19 symptoms. A drug side effect is also unlikely, because it takes around 2-3 weeks for a drug to cause various lesions. The additional observation of enanthem in patients with skin rashes suggests a viral origin rather than a drug side effect.”
Although further research in larger groups is needed to investigate this finding, the study also indicates that doctors should examine patients' mouths when assessing SARS-CoV-2.
A test to guide steroid treatment
New research shows that COVID-19 patients hospitalized with high levels of / severe infection may, with dexamethasone and other steroids, derive significant benefit. More studies are needed to determine which patients may benefit most from steroid treatment.
An important marker of inflammation, C-reactive protein (CRP), is also useful in deciding whether to administer steroids. In cases where CRP exceeded a specific value stated in the study, steroid use was found to affect the risk of death and needing a ventilator, significantly reducing it. Conversely, in patients with low CRP levels, steroid use substantially increases the risk of death and needing respiratory support. In view of these results, assessing CRP is said to be an extremely important starting point in determining treatment options for patients.
Combination treatment is effective in suppressing cytokine storm
In new studies, immune (immune system) suppressants methylprednisolone (a corticosteroid) and tocilizumab, when used together for cytokine release syndrome in COVID-19 patients, were associated with faster respiratory recovery, a lower likelihood of requiring mechanical ventilation and fewer hospital deaths.
COVID-19-associated cytokine release storm syndrome occurs in approximately 25% of intensive care patients. Researchers say more studies and evidence are needed, particularly to treat hospitalized COVID-19 patients with severe symptoms. They emphasize that the study is extremely interesting and that tocilizumab may be used with corticosteroids when necessary to improve treatment responses.
Commenting on the study in which more than 79% of COVID-19 patients treated in intensive care with combined methylprednisolone and tocilizumab showed substantial improvement in respiratory distress, Dr. Nihar R. Desai says: “Although these data are not randomized and come from a relatively small group of participants, they support the recent UK-based study demonstrating benefits of steroid use in COVID-19. Taken together, these results suggest it may be possible to say that steroid treatment provides benefit in these patients.”
Chronic COVID-19
According to the latest data from the US Centers for Disease Control and Prevention (US-CDC), even young adults and outpatients without chronic conditions experience long-term / chronic COVID-19.
The team conducted a telephone survey of symptomatic adults who tested positive for SARS-CoV-2. According to the survey, 35% had not returned to their normal state of health 2 to 3 weeks after testing. Of the 274 people interviewed, 270 said they had regained their health, and 175 (65%) said they had returned to their previous state of health within an average of 7 days after the test date.
The study included different age groups. Among interviewees aged 18-34, 26% reported that they had not returned to their normal state of health within 14 to 21 days after receiving a positive test result, as did 32% of those aged 35-49 and 47% of those aged at least 50.
Can SARS-CoV-2 damage the endocrine / hormonal system?
Researchers think SARS-CoV-2, which causes COVID-19, may disrupt various endocrine / hormonal functions through its effects on angiotensin-converting enzyme 2 (ACE2), which allows the virus to attach to and enter the body.
Earlier studies indicate that ACE2 production and its function in endocrine tissues may affect coronavirus. However, because there are insufficient data on ACE2 production in endocrine tissues under pathological conditions, researchers cannot definitively interpret the effects of ACE2 production on severe COVID-19 outcomes.
Does SARS-CoV-2 spread through the air?
Concerns about the airborne spread and transmission of SARS-CoV-2 have been voiced for several months. Rising case numbers are increasing these concerns, and research on the subject is expanding (our findings so far indicate that SARS-CoV-2 is primarily transmitted through respiratory droplets as the route of transmission).
A study published in a journal presents evidence of airborne spread. This once again shows that social distancing alone is not enough and wearing masks is also extremely important. Commenting on the issue, the World Health Organization (WHO) stated its position as follows: “Prolonged time together with infected people, particularly in enclosed, poorly ventilated and crowded settings, cannot be overlooked”.
The role of air conditioning in airborne coronavirus transmission is also being investigated. HVAC systems recirculate air, particularly when it is hot outside. When outdoor temperatures are very high, indoor air circulates more, causing people inside to breathe a higher proportion of air exhaled by others. The fan components of air conditioners may also provide extra lift that allows coronavirus aerosols (the dispersion of a solid or liquid in a gaseous medium) to remain suspended in the air longer.
More research on this issue is needed, considering healthcare workers' safety and the measures required for the approaching new school term.
Conclusion
New studies are increasing our knowledge of the COVID-19 pandemic every day. During this time, we can protect ourselves and our loved ones by paying attention to hand hygiene, maintaining social distance and taking care to wear masks even at home when necessary.
*
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.